Mirader 25
- Mirader effectively tackles symptoms of overactive bladder (OAB) syndrome in adults, including urgency, increased urination frequency, and urgency incontinence.
- Powered by mirabegron, the pioneering beta-3 adrenoceptor agonist, it optimizes bladder capacity via dual mechanisms: direct action on bladder smooth muscle and modulation of the sensory nervous system.
- Starting with a recommended dose of 25 mg tablet once daily, Mirader offers flexibility for dosage adjustment based on individual patient response and tolerance.
- Convenient administration: Simply swallow the tablet whole with liquids, without the need for chewing or crushing, ensuring ease of use in daily routines.